North Thames NHS Genomic Medicine Centre
North Thames NHS Genomic Medicine Centre is one of five designations within UCLPartners that work together to harness research and innovation for better patient care and a healthier population.
The North Thames NHS Genomic Medicine Centre (NTGMC) has been set up to help gain a better understanding of the genetic causes of cancer and rare disease. It is part of the Government’s 100,000 Genomes Project which aims to sequence, or analyse, 100,000 genomes from participants with cancer and rare disorders. The North Thames GMC is currently one of 13 regional Genomic Medicine Centres in England.
Seven hospital trusts in north London have formed a partnership to create the North Thames NHS Genomic Medicine Centre. Led by Great Ormond Street Hospital for Children NHS Foundation Trust, the other trusts involved in the partnership are Barts Health NHS Trust, London North West Healthcare NHS Trust, Moorfields Eye Hospital NHS Foundation Trust, the Royal Free London NHS Foundation Trust, Royal National Orthopaedic Hospital NHS Trust and University College London Hospitals NHS Foundation Trust (UCLH). Each of these hospital trusts will be participating in the 100,000 Genome Project.
People who are eligible to take part in the project will be identified by their doctor and asked to provide blood, or blood and tumour samples for genetic sequencing. For rare diseases some unaffected family members are asked to give consent to take part in the study.
The North Thames GMC is currently one of 13 regional Genomic Medicine Centres in England.
Find out more about the North Thames GMC.